sideBack

From Professor Sir Chris Evans’ initial scientific experiments in a converted sheep shed near Cambridge in 1988, to the pre-eminent medical science investment boutique and provider of healthcare facilities in Europe today. This is Excalibur

Excalibur is at once an investor, practitioner, scientist, adviser, enabler, facilitator and provider of medical and healthcare facilities. Our people have a wealth of experience and expertise and occupy a unique position at the centre of a global partner network of scientists, researchers, universities, start-ups and spin-outs, small biotechs, contract research organisations and big Pharma companies and the UK’s leading providers of medical and health facilities.

This includes the Excalibur Healthcare Consortium of architects, project managers, engineering and design consultants, construction firms, equipment and supply companies. In order to ensure the highest level of ethical standards, professional competence and clinical excellence in all the facilities we build, Excalibur also works closely with several Royal Colleges, NHS Trusts and leading UK universities and teaching hospitals.

We connect our clients to this global network.

Excalibur combines global medicine and global finance. We are the link between research, development, production, commercialisation, supply and distribution of drugs, devices, diagnostics and facilities with individual and institutional investors, equity and debt markets, start-up and expansion capital, strategic advice, and ultimately trade sale or flotation.

We are deal makers – university spin-outs, start-ups, growth and expansion capital, MBOs, M&A – and have completed financings from $1m to $1bn. We have completed transactions based on single pieces of Intellectual Property and on portfolios of over 50 pieces of IP.

Excalibur is a development of Merlin Biosciences, founded by Sir Chris, and is actively involved in funding new clinical research to develop drugs, diagnostics, devices, providing financing and advice.

Through our own FCA-regulated Fund Management arm, Excalibur Fund Managers, we are investors in global healthcare and finance or co-invest in specific projects.  We manage over $700m under the “Merlin” brand and have recently announced the launch of the $150m Wales Life Sciences Fund, to be seeded by the Welsh Government.

We are active in corporate finance and advisory, building highly successful companies from scratch, and are expert in devising growth strategies, capital raising, mergers and acquisitions, flotations, spin-offs and trades sales.

We have built state of the art medical facilities, including hospitals and healthcare services, research laboratories, production facilities, distribution centres, clinics, and mobile and emergency units.